Metafoodx | $9,400,000 | (May 16, 2025)
Ascendx | $110,000,000 | (May 16, 2025)
Algoma | $2,300,000 | (May 16, 2025)
DNA Script
France
- Le Kremlin-Bicêtre, Île-de-France
- 26/10/2021
- Series C
- $165,000,000
DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine.
- Industry Biotechnology Research
- Website https://www.dnascript.com/
- LinkedIn https://www.linkedin.com/company/dna-script/about/
Related People
Thomas YbertCo Founder
France -
Paris, Île-de-France
I founded DNA Script, in 2014, to tackle one of the major challenges in life sciences: being able to write DNA as fast and as simple as reading DNA.
DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAX™️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine.
Plakar | $3,000,000 | (May 16, 2025)
Solestial, Inc. | $17,000,000 | (May 16, 2025)
Adyton PBC | $11,000,000 | (May 16, 2025)
Sproutr | Undisclosed Amount | (May 16, 2025)
Voltra | $1,800,000 | (May 16, 2025)
IMPRINT(US) | $15,000,000 | (May 16, 2025)
Sprinter Health | $55,000,000 | (May 16, 2025)
CarbonSix | $4,000,000 | (May 16, 2025)
Zeno Power | $50,000,000 | (May 16, 2025)